Authors:
Ogilvie, ALJ
Antoni, C
Dechant, C
Manger, B
Kalden, JR
Schuler, G
Luftl, M
Citation: Alj. Ogilvie et al., Treatment of psoriatic arthritis with antitumour necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexate, BR J DERM, 144(3), 2001, pp. 587-589
Authors:
Kraetsch, HG
Antoni, C
Kalden, JR
Manger, B
Citation: Hg. Kraetsch et al., Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences, ANN RHEUM D, 60, 2001, pp. III55-III57
Authors:
Lorenz, HM
Grunke, M
Hieronymus, T
Antoni, C
Nusslein, H
Schaible, TF
Manger, B
Kalden, JR
Citation: Hm. Lorenz et al., In vivo blockade of tumor necrosis factor-alpha in patients with rheumatoid arthritis: Longterm effects after repeated infusion of chimeric monoclonal antibody cA2, J RHEUMATOL, 27(2), 2000, pp. 304-310
Citation: C. Antoni et Jr. Kalden, Combination therapy of the chimeric monoclonal anti-tumor necrosis factor alpha antibody (infliximab) with methotrexate in patients with rheumatoid arthritis, CLIN EXP RH, 17(6), 1999, pp. S73-S77
Authors:
Charles, P
Elliott, MJ
Davis, D
Potter, A
Kalden, JR
Antoni, C
Breedveld, FC
Smolen, JS
Eberl, G
deWoody, K
Feldmann, M
Maini, RN
Citation: P. Charles et al., Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis, J IMMUNOL, 163(3), 1999, pp. 1521-1528